Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+27.2%
5Y CAGR+25.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+27.2%/yr
vs +38.2%/yr prior
5Y CAGR
+25.6%/yr
Consistent
Acceleration
-11.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$40.50M-2.4%
2024$41.48M+26.8%
2023$32.71M+66.1%
2022$19.69M+62.3%
2021$12.13M-6.3%
2020$12.95M+71.0%
2019$7.57M+40.2%
2018$5.40M+7.7%
2017$5.01M+109.0%
2016$2.40M-